600200 Stock Overview
JiangSu WuZhong Pharmaceutical Development Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 600200 from our risk checks.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.88 |
| 52 Week High | CN¥13.88 |
| 52 Week Low | CN¥6.90 |
| Beta | 0.20 |
| 11 Month Change | -1.89% |
| 3 Month Change | 14.62% |
| 1 Year Change | 8.57% |
| 33 Year Change | 39.55% |
| 5 Year Change | 100.41% |
| Change since IPO | 76.43% |
Recent News & Updates
Health Check: How Prudently Does JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Use Debt?
Sep 25
Sentiment Still Eluding JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)
Jul 31Recent updates
Health Check: How Prudently Does JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Use Debt?
Sep 25Sentiment Still Eluding JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)
Jul 31JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt
Jun 06Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)
Mar 12Shareholder Returns
| 600200 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.4% | -1.4% | -2.0% |
| 1Y | 8.6% | -6.0% | 4.6% |
Return vs Industry: 600200 exceeded the CN Pharmaceuticals industry which returned -6% over the past year.
Return vs Market: 600200 exceeded the CN Market which returned 4.6% over the past year.
Price Volatility
| 600200 volatility | |
|---|---|
| 600200 Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600200 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600200's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,050 | Qunshan Qian | www.600200.com |
JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Fundamentals Summary
| 600200 fundamental statistics | |
|---|---|
| Market cap | CN¥6.96b |
| Earnings (TTM) | -CN¥37.82m |
| Revenue (TTM) | CN¥2.38b |
2.9x
P/S Ratio-184.0x
P/E RatioIs 600200 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600200 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.38b |
| Cost of Revenue | CN¥1.70b |
| Gross Profit | CN¥685.10m |
| Other Expenses | CN¥722.92m |
| Earnings | -CN¥37.82m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.054 |
| Gross Margin | 28.74% |
| Net Profit Margin | -1.59% |
| Debt/Equity Ratio | 93.1% |
How did 600200 perform over the long term?
See historical performance and comparison